Faculty of Pharmacy, Universiti Teknologi MARA and Rhazes Consultancy Services Sdn. Bhd signed a memorandum of understanding (MoU) in pharmaceutical healthcare focusing on collaboration to develop and enhance quality education and expertise in tele-pharmacy and digital health. The signing ceremony was held on the 24 December 2021 at UiTM Puncak Alam Campus, Selangor, Malaysia.
The MoU was signed by the Dean of Faculty of Pharmacy, UiTM, Associate Professor Dr Shariza Sahudin, and Chief Executive Officer, Rhazes Consultancy Services Sdn. Bhd., Mr Munaver Ahmad b Nazir Ahmad. The signing ceremony was also attended by the Chief Operating Officer of Rhazes Consultancy Services, Pn. Noorasmah bt Mohamed Noordin and UiTM’s Faculty of Pharmacy’s Deputy Dean (Industry, Community, Alumni & Network), Dr Muhamad Faiz Othman, and the Head of Department (Pharmacy Practice), Dr Mahmathi Karuppannan.
According to Associate Professor Dr Shariza Sahudin, the collaborative partnership with Rhazes Consultancy Services, a leading organization providing tele-pharmacy services, aligns with the Faculty of Pharmacy’s objective to pioneer tele-pharmacy development in Malaysia. “I believe through this collaboration, the tele-pharmacy expertise led by Rhazes Consultancy Services can be further developed”, she said. Associate Professor Dr Shariza Sahudin added that future collaborative work between Rhazes Consultancy Services and the Faculty of Pharmacy UiTM is expected to address the pressing demand to develop and enhance the skills and knowledge in digital pharmaceutical healthcare among pharmacy graduates given the shift to online platforms mainly due to IR4.0 and the Covid19 pandemic.
Rhazes Consultancy Services is a digital pharmacy technology service provider that connects the public with consultants, specialists, and subject matter experts in pharmaceutical healthcare. Coming from various fields of pharmaceutical practice, experts from Rhazers can provide unbiased, accurate, reliable, and quality advice and guidance on health, diseases, medication, and current health issues to future practitioners. Currently, the organisation provides digital pharmaceutical healthcare services such as medication management, quit-smoking programme, asthma disease management, and diabetic medication therapy adherence clinic.
The collaborative effort between both parties following the MoU signing is anticipated to produce substantial engagement initiatives towards providing high-quality and up-to-date pharmacy educational programmes and ensuring excellence in the profession of pharmacy.